Evidence map›Paper›PMID 36080676›Full record

ArticlePolymers2022

Antibacterial Activity of Silver Nanoflake (SNF)-Blended Polysulfone Ultrafiltration Membrane.

Gunawan Setia Prihandana, Tutik Sriani, Aisyah Dewi Muthi'ah, Siti Nurmaya Musa, Mohd Fadzil Jamaludin, Muslim Mahardika

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Gunawan Setia PrihandanaDepartment of Industrial Engineering, Faculty of Advanced Technology and Multidiscipline, Universitas Airlangga, Jl. Dr. Ir. H. Soekarno, Surabaya 60115, Indonesia.ORCID 0000-0003-3709-2036
Tutik SrianiDepartment of Research and Development, PT. Global Meditek Utama, Sardonoharjo, Ngaglik, Sleman, Yogyakarta 55581, Indonesia.
Aisyah Dewi Muthi'ahDepartment of Industrial Engineering, Faculty of Advanced Technology and Multidiscipline, Universitas Airlangga, Jl. Dr. Ir. H. Soekarno, Surabaya 60115, Indonesia.ORCID 0000-0002-3198-3738
Siti Nurmaya MusaCentre of Advanced Manufacturing & Material Processing (AMMP Centre), Department of Mechanical Engineering, Faculty of Engineering, Universiti Malaya, Kuala Lumpur 50603, Malaysia.ORCID 0000-0002-5165-4106
Mohd Fadzil JamaludinCentre of Advanced Manufacturing & Material Processing (AMMP Centre), Department of Mechanical Engineering, Faculty of Engineering, Universiti Malaya, Kuala Lumpur 50603, Malaysia.
Muslim MahardikaDepartment of Mechanical and Industrial Engineering, Faculty of Engineering, Universitas Gadjah Mada, Jalan Grafika No. 2, Yogyakarta 55281, Indonesia.
Airlangga University · IDUniversity of Malaya · MYUniversitas Gadjah Mada · ID

Funding

Hibah SATU Joint Research Scheme, Airlangga University Grant No. 1307/UN3.15/PT/2021
6 · The paper itself

Abstract

The aim of this research was to study the possibility of using silver nanoflakes (SNFs) as an antibacterial agent in polysulfone (PSF) membranes. SNFs at different concentrations (0.1, 0.2, 0.3 and 0.4 wt.%) were added to a PSF membrane dope solution. To investigate the effect of SNFs on membrane performance and properties, the water contact angle, protein separation, average pore size and molecular weight cutoffs were measured, and water flux and antibacterial tests were conducted. The antimicrobial activities of the SNFs were investigated using

Indexed as

antibacterial activityEscherichia coligood healthpolysulfone membranesilver nanoflakewater treatment

Identifiers

PMID36080676
PMCPMC9459915
OpenAlexW4294253252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.